Skip to main content
SpringerLink
Log in

Prostate Cancer Detection Using a Noninvasive Method for Quantifying miRNAs

  • Protocol
  • First Online:
Cancer Cell Signaling

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1165))

  • 3595 Accesses

Abstract

Cancer is one of the diseases with more incidence in industrialized countries. Early detection is important for patient survival in terms of treatment and clinical decisions. Several methods have been described to improve detection, diagnostic, and treatment in cancer, but the diagnostic methods are very aggressive for patients. Biopsies have been the gold standard to determine the clinical pathological characteristics of cancer tissues for many years. The biopsies procedure is very uncomfortable for the patients, and in many cases the results are negative to cancer. Therefore, patients are submitted to a second round of biopsies, because their clinical conditions implicate the presence of neoplasia. During the last years, noninvasive methods have shown relevance because they could be good indicators for cancer detection at molecular level. Molecular signatures have been included to characterize different stages of the disease, and thereby the objective is to prevent unnecessary biopsies. Several body fluids as urine, serum, blood, semen, saliva, etc. have been used. In fluids, miRNA detection provides a promising tool to obtain molecular signatures for different types of cancer. Urine represents a very good option to find molecules representative of tumor status in prostate cancer. The presence or the absence of miRNA involved in the development of the disease has been demonstrated. In this chapter we describe a method to quantify mature miRNA signatures using a noninvasive test using a body fluid such as urine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO (2013) Cancer mortality and morbidity. http://www.who.int/gho/ncd/mortality_morbidity/cancer_text/en/index.html

  2. Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E (eds) (2003) Cancer medicine, 6th edn. Hamilton, MA: BC Decker

    Google Scholar 

  3. Hanahan D, Weinberg RA (2000) The Hallmarks of cancer. Cell 100:57–70

    Article  CAS  PubMed  Google Scholar 

  4. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

    Article  CAS  PubMed  Google Scholar 

  5. GLOBOCAN (2008) Prostate cancer incidence, mortality and prevalence worldwide in 2008, GLOBOCAN Project. http://globocan.iarc.fr/.

  6. Narain V, Cher ML, Wood DP Jr (2002) Prostate cancer diagnosis, staging and survival. Cancer Metastasis Rev 21:17–27

    Article  PubMed  Google Scholar 

  7. Hansen LL (2006) Molecular diagnosis of breast cancer, in prevention and treatment of age-related diseases. Springer, The Netherlands

    Google Scholar 

  8. Kohler C, Barekati Z, Radpour R et al (2011) Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res 31:2623–2628

    CAS  PubMed  Google Scholar 

  9. Pathak AK, Bhutani M, Kumar S et al (2006) Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 52:1833–1842

    CAS  PubMed  Google Scholar 

  10. Wroclawski ML, Serpa-Neto A, Fonseca NL et al (2013) Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients. Tumour Biol 34:2921–2927

    Article  CAS  PubMed  Google Scholar 

  11. Allegra A, Alonci A, Campo S et al (2012) Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 41:1897–1912

    CAS  PubMed  Google Scholar 

  12. Filella X, Foj L, Milá M et al (2013) PCA3 in the detection and management of early prostate cancer. Tumour Biol 34:1337–1347

    Article  CAS  PubMed  Google Scholar 

  13. Roobol MJ, Haese A, Bjartell A (2011) Tumour markers in prostate cancer III: biomarkers in urine. Acta Oncol 50(Suppl 1):85–89

    Article  CAS  PubMed  Google Scholar 

  14. Weber JA, Baxter DH, Zhang S et al (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56:1733–1741

    Article  CAS  PubMed  Google Scholar 

  15. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114

    Article  CAS  PubMed  Google Scholar 

  16. Rana TM (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 8:23–36

    Article  CAS  PubMed  Google Scholar 

  17. Brennecke J, Hipfner DR, Stark A et al (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113:25–36

    Article  CAS  PubMed  Google Scholar 

  18. Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175–205

    Article  CAS  PubMed  Google Scholar 

  19. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854

    Article  CAS  PubMed  Google Scholar 

  20. Rajewsky N, Socci ND (2004) Computational identification of microRNA targets. Dev Biol 267:529–535

    Article  CAS  PubMed  Google Scholar 

  21. Calin GA, Dumitru CD, Shimizu M et al (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524–15529

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Calin GA, Sevignani C, Dumitru CD et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101:2999–3004

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Ambs S, Prueitt RL, Yi M et al (2008) Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68:6162–6170

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Calin GA, Ferracin M, Cimmino A et al (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793–1801

    Article  CAS  PubMed  Google Scholar 

  25. Calin GA, Liu CG, Sevignani C et al (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101:11755–11760

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Fassan M, Baffa R, Palazzo JP et al (2009) MicroRNA expression profiling of male breast cancer. Breast Cancer Res 11:R58

    Article  PubMed Central  PubMed  Google Scholar 

  27. Lorio MV, Visone R, Di Leva G et al (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67:8699–8707

    Article  Google Scholar 

  28. Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838

    Article  CAS  PubMed  Google Scholar 

  29. Tong AW, Fulgham P, Jay C et al (2009) MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 16:206–216

    CAS  PubMed  Google Scholar 

  30. Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103:2257–2261

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Kahlert C, Kalluri R (2013) Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med 91:431–437

    Article  CAS  PubMed  Google Scholar 

  32. Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513–10518

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto Nacional de Medicina Genómica, Periférico Sur No. 4809, Col. Arenal Tepepan, Delegación Tlalpan, México, DF, CP 14610, México

    Mauricio Rodríguez-Dorantes, A. Ivan Salido-Guadarrama & Pilar García-Tobilla

Authors
  1. Mauricio Rodríguez-Dorantes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Ivan Salido-Guadarrama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pilar García-Tobilla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mauricio Rodríguez-Dorantes .

Editor information

Editors and Affiliations

  1. Universidad Nacional Autónoma de México, Mexico D.F., Mexico

    Martha Robles-Flores

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Rodríguez-Dorantes, M., Salido-Guadarrama, A.I., García-Tobilla, P. (2014). Prostate Cancer Detection Using a Noninvasive Method for Quantifying miRNAs. In: Robles-Flores, M. (eds) Cancer Cell Signaling. Methods in Molecular Biology, vol 1165. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0856-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0856-1_7

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-0855-4

  • Online ISBN: 978-1-4939-0856-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation